Qingzhe Meng, Dunhui Liu, Junhong Huang, Xinjie Yang, Huan Li, Zihui Yang, Jun Wang, Wanpeng Gao, Yahui Li, Rong Liu, Liying Yang, Jianhua Wei
BACKGROUND: Head and Neck Squamous Cell Carcinoma (HNSCC) is a malignant tumor with a high degree of malignancy, invasiveness, and metastasis rate. Radiotherapy, as an important adjuvant therapy for HNSCC, can reduce the postoperative recurrence rate and improve the survival rate. Identifying the genes related to HNSCC radiotherapy resistance (HNSCC-RR) is helpful in the search for potential therapeutic targets. However, identifying radiotherapy resistance-related genes from tens of thousands of genes is a challenging task...
March 26, 2024: Current Radiopharmaceuticals